1. AB0080 In Both SLE and Seropositive RA, the Interleukin-6 (IL-6) System is Active, and Shifted towards Trans-Signalling. (10th June 2014) Authors: Skwarek, M.; Fantana, J.; Heschel, B.; Aringer, M. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0008 Evidence for increased activity of interleukin-6 (IL-6) in seropositive rheumatoid arthritis (RA+), and differential tumour necrosis factor (TNF) receptor expression between ra+ and seronegative ra. (23rd January 2014) Authors: Skwarek, M.; Heschel, B.; Fantana, J.; Aringer, M. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0083 Explaining Low C-Reactive Protein (CRP) Levels in Systemic Lupus Erythematosus (SLE): Reduced Membrane-Bound, Increased Soluble Interleukin-6 (IL-6) Receptors. (9th June 2015) Authors: Skwarek, M.; Heschel, B.; Fantana, J.; Aringer, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0192 Decreased Interleukin-6/STAT3, but Increased Interferon/STAT1 Signalling in Lymphocytes of Patients with Systemic Sclerosis (SSC). (15th July 2016) Authors: Kittel, C.; Skwarek, M.; Heschel, B.; Fantana, J.; Aringer, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗